The off-label use of 0.01% atropine drops is a safe and noninvasive way to treat symptomatic vitreous floaters, according to a study done by Mohsin H. Ali, M.D., who presented his findings today at the 43 rd annual meeting of the American Academy of Retina Specialists.

Floaters are small spots or lines that float across the field of vision caused by the clumping of vitreous strands, the shadows of which cast a shadow on the retina. They are classified as symptomatic vitreous floaters when symptoms become so severe a patient seeks treatment. Existing treatments include pars plana vitrectomy (PPV), in which a surgeon removes the vitreous gel and replaces it with saline, and YAG laser vitreolysis, which uses a laser to dissolve floaters. However, these measures can lead to potential visi

See Full Page